Systematic assessment of microRNA‐132 therapeutic targeting in Alzheimer’s disease

Abstract

Background: Mapping the mechanistic heterogeneity and multifactorial nature of AD is a key challenge for therapeutic development and the main reason why network biology and multi-modal therapies begin to attract attention also in AD research. miRNAtargeted therapeutics are particularly suited for such purposes, as they regulate